U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Increased risk for multiple myeloma

MedGen UID:
347254
•Concept ID:
C1856523
•
Finding

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVIncreased risk for multiple myeloma

Professional guidelines

PubMed

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel.
Raje N, Anderson K, Einsele H, Efebera Y, Gay F, Hammond SP, Lesokhin AM, Lonial S, Ludwig H, Moreau P, Patel K, Ramasamy K, Mateos MV
Blood Cancer J 2023 Aug 1;13(1):116. doi: 10.1038/s41408-023-00879-7. PMID: 37528088Free PMC Article
Bortezomib for the treatment of multiple myeloma.
Scott K, Hayden PJ, Will A, Wheatley K, Coyne I
Cochrane Database Syst Rev 2016 Apr 20;4(4):CD010816. doi: 10.1002/14651858.CD010816.pub2. PMID: 27096326Free PMC Article
Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
Cairo MS, Coiffier B, Reiter A, Younes A; TLS Expert Panel
Br J Haematol 2010 May;149(4):578-86. Epub 2010 Mar 16 doi: 10.1111/j.1365-2141.2010.08143.x. PMID: 20331465

Recent clinical studies

Etiology

Bone Disease in Multiple Myeloma: Biologic and Clinical Implications.
Bernstein ZS, Kim EB, Raje N
Cells 2022 Jul 27;11(15) doi: 10.3390/cells11152308. PMID: 35954151Free PMC Article
Roadmap to cure multiple myeloma.
Rodriguez-Otero P, Paiva B, San-Miguel JF
Cancer Treat Rev 2021 Nov;100:102284. Epub 2021 Aug 31 doi: 10.1016/j.ctrv.2021.102284. PMID: 34597912
Prognostic and predictive biomarker developments in multiple myeloma.
Wallington-Beddoe CT, Mynott RL
J Hematol Oncol 2021 Sep 23;14(1):151. doi: 10.1186/s13045-021-01162-7. PMID: 34556161Free PMC Article
Multiple myeloma.
Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, Gay F, Anderson KC
Nat Rev Dis Primers 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46. PMID: 28726797
Multiple myeloma.
Röllig C, Knop S, Bornhäuser M
Lancet 2015 May 30;385(9983):2197-208. Epub 2014 Dec 23 doi: 10.1016/S0140-6736(14)60493-1. PMID: 25540889

Diagnosis

Roadmap to cure multiple myeloma.
Rodriguez-Otero P, Paiva B, San-Miguel JF
Cancer Treat Rev 2021 Nov;100:102284. Epub 2021 Aug 31 doi: 10.1016/j.ctrv.2021.102284. PMID: 34597912
Prognostic and predictive biomarker developments in multiple myeloma.
Wallington-Beddoe CT, Mynott RL
J Hematol Oncol 2021 Sep 23;14(1):151. doi: 10.1186/s13045-021-01162-7. PMID: 34556161Free PMC Article
Myeloma light chain cast nephropathy, a review.
Sathick IJ, Drosou ME, Leung N
J Nephrol 2019 Apr;32(2):189-198. Epub 2018 May 5 doi: 10.1007/s40620-018-0492-4. PMID: 29730782
Multiple myeloma.
Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, Gay F, Anderson KC
Nat Rev Dis Primers 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46. PMID: 28726797
Multiple myeloma.
Röllig C, Knop S, Bornhäuser M
Lancet 2015 May 30;385(9983):2197-208. Epub 2014 Dec 23 doi: 10.1016/S0140-6736(14)60493-1. PMID: 25540889

Therapy

Bone Disease in Multiple Myeloma: Biologic and Clinical Implications.
Bernstein ZS, Kim EB, Raje N
Cells 2022 Jul 27;11(15) doi: 10.3390/cells11152308. PMID: 35954151Free PMC Article
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score.
Sanfilippo KM, Luo S, Wang TF, Fiala M, Schoen M, Wildes TM, Mikhael J, Kuderer NM, Calverley DC, Keller J, Thomas T, Carson KR, Gage BF
Am J Hematol 2019 Nov;94(11):1176-1184. Epub 2019 Aug 19 doi: 10.1002/ajh.25603. PMID: 31379000Free PMC Article
Multiple myeloma.
Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, Gay F, Anderson KC
Nat Rev Dis Primers 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46. PMID: 28726797
Bortezomib for the treatment of multiple myeloma.
Scott K, Hayden PJ, Will A, Wheatley K, Coyne I
Cochrane Database Syst Rev 2016 Apr 20;4(4):CD010816. doi: 10.1002/14651858.CD010816.pub2. PMID: 27096326Free PMC Article
Multiple myeloma.
Röllig C, Knop S, Bornhäuser M
Lancet 2015 May 30;385(9983):2197-208. Epub 2014 Dec 23 doi: 10.1016/S0140-6736(14)60493-1. PMID: 25540889

Prognosis

Prognostic and predictive biomarker developments in multiple myeloma.
Wallington-Beddoe CT, Mynott RL
J Hematol Oncol 2021 Sep 23;14(1):151. doi: 10.1186/s13045-021-01162-7. PMID: 34556161Free PMC Article
Myeloma light chain cast nephropathy, a review.
Sathick IJ, Drosou ME, Leung N
J Nephrol 2019 Apr;32(2):189-198. Epub 2018 May 5 doi: 10.1007/s40620-018-0492-4. PMID: 29730782
Multiple myeloma.
Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, Gay F, Anderson KC
Nat Rev Dis Primers 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46. PMID: 28726797
Multiple myeloma.
Röllig C, Knop S, Bornhäuser M
Lancet 2015 May 30;385(9983):2197-208. Epub 2014 Dec 23 doi: 10.1016/S0140-6736(14)60493-1. PMID: 25540889
IMWG consensus on risk stratification in multiple myeloma.
Chng WJ, Dispenzieri A, Chim CS, Fonseca R, Goldschmidt H, Lentzsch S, Munshi N, Palumbo A, Miguel JS, Sonneveld P, Cavo M, Usmani S, Durie BG, Avet-Loiseau H; International Myeloma Working Group
Leukemia 2014 Feb;28(2):269-77. Epub 2013 Aug 26 doi: 10.1038/leu.2013.247. PMID: 23974982

Clinical prediction guides

The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.
Huang J, Chan SC, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, Zheng ZJ, Elcarte E, Withers M, Wong MCS; Non-communicable Disease Global Health Research Group, Association of Pacific Rim Universities
Lancet Haematol 2022 Sep;9(9):e670-e677. Epub 2022 Jul 14 doi: 10.1016/S2352-3026(22)00165-X. PMID: 35843248
Prognostic and predictive biomarker developments in multiple myeloma.
Wallington-Beddoe CT, Mynott RL
J Hematol Oncol 2021 Sep 23;14(1):151. doi: 10.1186/s13045-021-01162-7. PMID: 34556161Free PMC Article
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM).
Mateos MV, Kumar S, Dimopoulos MA, González-Calle V, Kastritis E, Hajek R, De Larrea CF, Morgan GJ, Merlini G, Goldschmidt H, Geraldes C, Gozzetti A, Kyriakou C, Garderet L, Hansson M, Zamagni E, Fantl D, Leleu X, Kim BS, Esteves G, Ludwig H, Usmani S, Min CK, Qi M, Ukropec J, Weiss BM, Rajkumar SV, Durie BGM, San-Miguel J
Blood Cancer J 2020 Oct 16;10(10):102. doi: 10.1038/s41408-020-00366-3. PMID: 33067414Free PMC Article
Multiple myeloma.
Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, Gay F, Anderson KC
Nat Rev Dis Primers 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46. PMID: 28726797
Bortezomib for the treatment of multiple myeloma.
Scott K, Hayden PJ, Will A, Wheatley K, Coyne I
Cochrane Database Syst Rev 2016 Apr 20;4(4):CD010816. doi: 10.1002/14651858.CD010816.pub2. PMID: 27096326Free PMC Article

Recent systematic reviews

Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis.
Reynolds G, Cliff ERS, Mohyuddin GR, Popat R, Midha S, Liet Hing MN, Harrison SJ, Kesselheim AS, Teh BW
Blood Adv 2023 Oct 10;7(19):5898-5903. doi: 10.1182/bloodadvances.2023010539. PMID: 37467036Free PMC Article
The effects of physical exercise in the palliative care phase for people with advanced cancer: a systematic review with meta-analysis.
Toohey K, Chapman M, Rushby AM, Urban K, Ingham G, Singh B
J Cancer Surviv 2023 Apr;17(2):399-415. Epub 2022 Jan 18 doi: 10.1007/s11764-021-01153-0. PMID: 35040076
Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H, Liu S, Wang Y, Xu D, Li M, Zhao Y, Zeng X
Autoimmun Rev 2022 May;21(5):103084. Epub 2022 Mar 24 doi: 10.1016/j.autrev.2022.103084. PMID: 35341972
Bortezomib for the treatment of multiple myeloma.
Scott K, Hayden PJ, Will A, Wheatley K, Coyne I
Cochrane Database Syst Rev 2016 Apr 20;4(4):CD010816. doi: 10.1002/14651858.CD010816.pub2. PMID: 27096326Free PMC Article
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M
Lancet 2008 Feb 16;371(9612):569-78. doi: 10.1016/S0140-6736(08)60269-X. PMID: 18280327

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...